menu
{ "item_title" : "Multimodal Biomarkers for Central Nervous System Disorders", "item_author" : [" National Academies of Sciences Engineeri", "Health and Medicine Division", "Board on Health Sciences Policy "], "item_description" : "A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development. Recent technological advances have led to an increased number of biomarkers for different CNS disorders, providing the opportunity to generate multimodal biomarkers. While multimodal biomarkers can serve as promising tools to better diagnose and make accurate disease assessments, there remain challenges in current data collection, standardization, and validation practices that impede in their development. Recognizing the need for increased CNS biomarker integration, the National Academies Forum on Neuroscience and Nervous System Disorders hosted a public workshop in March 2023 to explore steps toward this goal, including data collection for biomarker discovery, development, validation, and assessment of clinical utility. This Proceedings of a Workshop summarizes the discussions held during the workshop.", "item_img_path" : "https://covers3.booksamillion.com/covers/bam/0/30/970/847/0309708478_b.jpg", "price_data" : { "retail_price" : "18.00", "online_price" : "18.00", "our_price" : "18.00", "club_price" : "18.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Multimodal Biomarkers for Central Nervous System Disorders|National Academies of Sciences Engineeri

Multimodal Biomarkers for Central Nervous System Disorders : Development, Validation, and Clinical Integration: Proceedings of a Workshop

local_shippingShip to Me
On Order. Usually ships in 2-4 weeks
FREE Shipping for Club Members help

Overview

A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development. Recent technological advances have led to an increased number of biomarkers for different CNS disorders, providing the opportunity to generate multimodal biomarkers. While multimodal biomarkers can serve as promising tools to better diagnose and make accurate disease assessments, there remain challenges in current data collection, standardization, and validation practices that impede in their development. Recognizing the need for increased CNS biomarker integration, the National Academies Forum on Neuroscience and Nervous System Disorders hosted a public workshop in March 2023 to explore steps toward this goal, including data collection for biomarker discovery, development, validation, and assessment of clinical utility. This Proceedings of a Workshop summarizes the discussions held during the workshop.

This item is Non-Returnable

Customers Also Bought

Details

  • ISBN-13: 9780309708470
  • ISBN-10: 0309708478
  • Publisher: National Academies Press
  • Publish Date: November 2023
  • Page Count: 82

Related Categories

You May Also Like...

    1

BAM Customer Reviews